Can you categorize the penicillins (benzylpenicillin, amoxicillin, ampicillin, flucloxacillin, and amoxicillin‑clavulanate) by their chemical structure, antimicrobial activity, and clinical indications?

Penicillin Classification: Structure, Activity, and Indications

Overview of Penicillin Categories

Penicillins are classified into distinct groups based on their chemical structure and spectrum of antimicrobial activity, progressing from narrow-spectrum natural penicillins to broader-spectrum agents with β-lactamase inhibitor combinations. 1

---

1. Natural Penicillins: Benzylpenicillin (Penicillin G)

Structure

• Contains the basic β-lactam ring with minimal side-chain modifications
• Available as benzathine salt for prolonged intramuscular depot effect 2

Antimicrobial Activity

• Narrow spectrum: Primarily gram-positive cocci (Streptococcus pyogenes, Streptococcus pneumoniae)
• Active against Group B Streptococcus (GBS) and some anaerobes
• Susceptible to β-lactamase degradation - ineffective against penicillinase-producing Staphylococcus aureus 1
• Recent evidence demonstrates superiority over anti-staphylococcal penicillins for penicillin-susceptible S. aureus (PSSA) bacteremia, with lower mortality trends and significantly reduced acute kidney injury 3

Clinical Indications

• Early-onset neonatal sepsis (first 72 hours): Combined with gentamicin as first-line empirical treatment 4
• Mild-to-moderate upper respiratory tract infections caused by susceptible streptococci 2
• Syphilis treatment: Early syphilis (primary/secondary), latent syphilis, yaws, pinta 2
• Prophylaxis: Rheumatic fever recurrence, post-streptococcal glomerulonephritis, erysipelas 2

---

2. Aminopenicillins: Amoxicillin and Ampicillin

Structure

• Addition of amino group to the acyl side chain extends gram-negative coverage 1
• Amoxicillin replaced ampicillin due to superior oral bioavailability and higher serum concentrations 5

Antimicrobial Activity

• Extended spectrum compared to benzylpenicillin
• Gram-positive: Streptococci, Enterococcus faecalis
• Gram-negative: Escherichia coli, Proteus mirabilis, Haemophilus influenzae (non-β-lactamase producing), Salmonella, Shigella, Listeria 1
• Still susceptible to β-lactamase degradation - ineffective against most Staphylococcus aureus and many H. influenzae strains

Clinical Indications

• Ampicillin: Added to cephalosporin-metronidazole regimens for severe intra-abdominal infections to provide enterococcal coverage 4
• Amoxicillin: First-line for acute otitis media, community-acquired pneumonia in children, uncomplicated urinary tract infections
• Both used in neonatal sepsis protocols combined with aminoglycosides 4

---

3. Penicillinase-Resistant Penicillins: Flucloxacillin

Structure

• Bulky acyl side chain sterically protects the β-lactam ring from staphylococcal β-lactamases 1

Antimicrobial Activity

• Narrow spectrum: Specifically designed for penicillinase-producing Staphylococcus aureus (methicillin-susceptible S. aureus, MSSA)
• Less active than benzylpenicillin against streptococci
• No activity against gram-negative bacteria or MRSA

Clinical Indications

• Skin and soft tissue infections caused by MSSA
• Staphylococcal bacteremia and endocarditis (MSSA)
• Important caveat: Recent evidence shows benzylpenicillin is superior to flucloxacillin for PSSA bacteremia, with 50% lower risk of acute kidney injury (adjusted OR 0.50,95% CrI 0.26-0.94) 3

---

4. β-Lactamase Inhibitor Combinations: Amoxicillin-Clavulanate

Structure

• Combines amoxicillin with clavulanic acid, a β-lactam structurally related to penicillins
• Clavulanic acid acts as a "suicide inhibitor" of bacterial β-lactamases 6
• Available in multiple ratios: original 4:1, then 7:1, and high-dose 14:1 (600 mg amoxicillin per 5 mL) 5

Antimicrobial Activity

• Broadest spectrum among oral penicillins
• Gram-positive: Staphylococcus aureus (MSSA), Streptococcus pneumoniae, Streptococcus pyogenes
• Gram-negative: E. coli, Klebsiella species, H. influenzae (including β-lactamase producers), Moraxella catarrhalis, Enterobacter species 7
• Anaerobes: Bacteroides fragilis, Fusobacterium, Peptostreptococcus 7
• Clavulanic acid inactivates clinically important plasmid-mediated β-lactamases but not all resistance mechanisms 6

Clinical Indications

WHO AWaRe Classification: Access Group - prioritized for appropriate use with low resistance potential 4, 8

First-Line Indications:

• Mild-to-moderate intra-abdominal infections 4
• Acute bacterial rhinosinusitis: Recent 2026 evidence shows no difference in treatment failure compared to amoxicillin alone (3.0% vs 3.1%), but higher risk of secondary infections including yeast infections (1.1% vs 0.8%) and C. difficile (0.04% vs 0.02%) 9
• Acute otitis media: High-dose formulation (90 mg/kg/day) recommended for recurrent/persistent cases or when drug-resistant S. pneumoniae suspected 5
• Community-acquired pneumonia in children and adults
• Chronic bronchitis exacerbations 8
• Skin and soft tissue infections (cellulitis)
• Urinary tract infections (complicated and uncomplicated) 6

Additional Uses:

• Intra-abdominal and pelvic sepsis (mixed aerobic/anaerobic) 6
• Bite wounds (animal/human)
• Dental infections

Dosing Considerations

• Standard dose: 875 mg-125 mg twice daily (adults) 7
• High dose pediatric: 90 mg/kg/day of amoxicillin component for resistant pathogens 5
• Absorption of clavulanate enhanced when taken with food 7
• Half-life: Amoxicillin 1.3 hours, clavulanic acid 1 hour 7

---

Key Clinical Pearls

Common Pitfalls to Avoid:

1. Do not use flucloxacillin for PSSA bacteremia - benzylpenicillin is superior with lower nephrotoxicity 3
2. Avoid amoxicillin-clavulanate for uncomplicated acute sinusitis - amoxicillin alone is equally effective with fewer adverse events 9
3. Do not use aminopenicillins alone for empiric staphylococcal coverage - most S. aureus produce β-lactamase
4. Recognize that clavulanate does not overcome all resistance mechanisms - ineffective against AmpC β-lactamases and carbapenemases

Stewardship Principles:

• Prioritize narrow-spectrum agents when pathogen known: Use benzylpenicillin for PSSA, not flucloxacillin 3
• Reserve amoxicillin-clavulanate for documented β-lactamase-producing organisms or when broader coverage necessary 8
• Use shortest effective duration to minimize resistance selection and adverse events
• Avoid in viral syndromes - no role in viral upper respiratory infections 8